IDX — Integral Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Integral Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	C2019 June 30th	R2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	21	58	62.2	123	33.9
Net Total Accounts Receivable
Net Total Receivables	10.3	12	18.3	24.3	23.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.8	76.5	82.3	154	62.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	70.8	190	211	231	282
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	315	587	655	783	839
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38.1	76.2	77.9	80	82.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	187	359	400	436	466
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	127	228	255	347	373
Total Liabilities & Shareholders' Equity	315	587	655	783	839
Total Common Shares Outstanding